In Reply to 'Plasma Clearance of Iohexol in Hemodialysis Patients Requires Prolonged Blood Sampling'

Tariq Shafi; Andrew S. Levey; Josef Coresh

doi:10.1053/j.ajkd.2016.01.023

In Reply to 'Plasma Clearance of Iohexol in Hemodialysis Patients Requires Prolonged Blood Sampling'

Tariq Shafi, Andrew S. Levey, Josef Coresh

Houston Methodist

Research output: Contribution to journal › Letter › peer-review

1 Scopus citations

Original language	English (US)
Pages (from-to)	811-812
Number of pages	2
Journal	American Journal of Kidney Diseases
Volume	67
Issue number	5
DOIs	https://doi.org/10.1053/j.ajkd.2016.01.023
State	Published - May 1 2016

ASJC Scopus subject areas

Nephrology

Access to Document

10.1053/j.ajkd.2016.01.023

Cite this

@article{045a9415716546c8b756272283e17b0f,

title = "In Reply to 'Plasma Clearance of Iohexol in Hemodialysis Patients Requires Prolonged Blood Sampling'",

author = "Tariq Shafi and Levey, {Andrew S.} and Josef Coresh",

note = "Funding Information: Financial Disclosure: Dr Shafi reports funding to Johns Hopkins University for research from the National Institutes of Health (NIH) and receiving speaker fees from Siemens. Dr Levey reports funding to Tufts Medical Center for research and contracts with the NIH, National Kidney Foundation (NKF), Amgen, Pharmalink AB, and Gilead Sciences. Dr Coresh reports funding to Johns Hopkins University for research and contracts with the NIH and NKF. Drs Levey and Coresh also have a provisional patent (Coresh, Inker, and Levey) filed August 15, 2014 (precise estimation of GFR from multiple biomarkers); licensing is under negotiation. ",

year = "2016",

month = may,

day = "1",

doi = "10.1053/j.ajkd.2016.01.023",

language = "English (US)",

volume = "67",

pages = "811--812",

journal = "American Journal of Kidney Diseases",

issn = "0272-6386",

publisher = "W.B. Saunders Ltd",

number = "5",

}

TY - JOUR

T1 - In Reply to 'Plasma Clearance of Iohexol in Hemodialysis Patients Requires Prolonged Blood Sampling'

AU - Shafi, Tariq

AU - Levey, Andrew S.

AU - Coresh, Josef

N1 - Funding Information: Financial Disclosure: Dr Shafi reports funding to Johns Hopkins University for research from the National Institutes of Health (NIH) and receiving speaker fees from Siemens. Dr Levey reports funding to Tufts Medical Center for research and contracts with the NIH, National Kidney Foundation (NKF), Amgen, Pharmalink AB, and Gilead Sciences. Dr Coresh reports funding to Johns Hopkins University for research and contracts with the NIH and NKF. Drs Levey and Coresh also have a provisional patent (Coresh, Inker, and Levey) filed August 15, 2014 (precise estimation of GFR from multiple biomarkers); licensing is under negotiation.

PY - 2016/5/1

Y1 - 2016/5/1

UR - http://www.scopus.com/inward/record.url?scp=84963976343&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84963976343&partnerID=8YFLogxK

U2 - 10.1053/j.ajkd.2016.01.023

DO - 10.1053/j.ajkd.2016.01.023

M3 - Letter

C2 - 27091016

AN - SCOPUS:84963976343

SN - 0272-6386

VL - 67

SP - 811

EP - 812

JO - American Journal of Kidney Diseases

JF - American Journal of Kidney Diseases

IS - 5

ER -

In Reply to 'Plasma Clearance of Iohexol in Hemodialysis Patients Requires Prolonged Blood Sampling'

ASJC Scopus subject areas

Access to Document

Other files and links

Cite this